Shanghai Zerun Biotechnology

NCT03900572

Phase 1, Completed, 2019, 90 people, 3 Apr 2019, clinicaltrials.gov

NCT02740790

Phase 2, Completed, 2013, 1,200 people, 15 Apr 2016, clinicaltrials.gov